169167 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
SCREENING FOR BONE ANABOLIC FACTORS
#602SCREENING METHOD WITH THE USE OF TBK1 KNOCKOUT MOUSE
#603Pan-Kinase Activation and Evaluation of Signaling Pathways
#604T1R taste receptors and genes encoding same
#605METHODS FOR PREDICTING PRODUCTION OF ACTIVATING SIGNALS BY CROSS-LINKED BINDING PROTEINS
#606Method of treating depression
#607Nucleic acids encoding T2R taste receptors
#608Methods for determining signal transduction activity in tumors
#609PARALLEL PROFILLING OF SIGNALING PATHWAYS
#610Agent for inhibiting cytokinin signaling
#611Method for determining human immunodeficiency virus (HIV) coreceptor utilization by examining gp41 molecular determinants
#612Compositions and methods for bone formation, bone remodeling and toxin protection
#613COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#614Nucleic acid sequences and their use in methods to identify umami modulatiors
#615Methods of using F-spondin as a biomarker for cartilage degenerative conditions and bone diseases
#616Methods for diagnosis, prognosis and methods of treatment
#617Inhibitors of the unfolded protein response and methods for their use
#618Methods of effecting Wnt signaling through Dkk structural analysis
#619Tissue protective erythropoietin receptor (NEPOR) and methods of use
#620Apparatus and methods for monitoring the status of a metabolically active cell
#621Methods for Determining Notch Signaling and Uses Thereof
#622In Vitro Assay Based on Camp Levels Modulated by Gi-Coupled Receptors
#623IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
#624METHODS TO IDENTIFY INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE
#625Human T1R2 taste receptor nucleic acids and cells containing these nucleic acids
#626System and method for performing G protein coupled receptor (GPCR) cell assays using waveguide-grating sensors
#627Biomarker Detection Assays
#628Screening method for binding property or signal transduction alterations
#629Diagnostics and Therapeutics For Glaucoma
#630Heteromeric taste receptors comprising T1R2/T1R3 domains
#631Heteromeric taste receptors
#632Heteromeric T1R2/T1R3 taste receptors
#633Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling
#634Increasing glucose transport and insulin-stimulated glucose uptake
#635Cell lines that express hetero oligomeric taste receptors
#636Methods of quantifying taste of compounds for food or beverages
#637Methods of using T1R2/T1R3 heteromeric receptors to quantify taste of compounds for food or beverages
#638Methods and compositions for inhibition of vascular permeability
#639Enhancing stem cell mobilization
#640Methods of inhibiting T1R1/T1R3 heteromeric umami taste receptors
#641Methods of screening T1R2/T1R3 receptors for compounds which modulate sweet taste signaling
#642Methods for diagnosis of cardiovascular disease
#643Compositions and methods for the prophylaxis or treatment of viral diseases
#644Methods of suppressing microglial activation and systemic inflammatory responses
#645Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors
#646Regulators of NFAT
#647Cellular assay method for identifying pkc-0 inhibitors
#648METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES
#649Method for conducting an assay for neutralizing antibodies
#650MODULATORS OF ODORANT RECEPTORS
#651Modulators of odorant receptors
#652MOLECULES INVOLVED IN SYNAPTOGENESIS AND USES THEREFOR
#653Method for identifying compounds that affect a transport of a protein through a membrane trafficking pathway
#654Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#655CELLULAR SIGNALING PATHWAY BASED ASSAYS, REAGENTS AND KITS
#656NPY Y2 Agonist for Use as Therapeutic Agent for Disease Accompanied by Diarrhea
#657Pyrvinium For The Treatment of Cancer
#658Methods for diagnosis prognosis and methods of treatment
#659Human T1R2 polypeptide functional assays
#660Modulators that promote cell surface expression of odorant receptors
#661Sour/Acid Taste Receptors Assays, Genes and Proteins
#662Methods of treating neurological conditions with hematopoeitic growth factors
#663123 Human Secreted Proteins
#664Methods and compositions for risk stratification
#665Methods for identifying compounds for the treatment of type 1 diabetes
#666Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells
#667Screening methods using GPR52
#668Device and methods for monitoring the status of at least one cell
#669METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#670Methods for Identifying Compounds for the Treatment of Type 1 Diabetes
#671Methods of screening modulators of hetero-oligomeric sweet taste receptors
#672Human T1R2 nucleic acid sequences and polypeptides
#673Drug selection for lung cancer therapy using antibody-based arrays
#674Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2
#675Npy Y4 Agonist as Therapeutic Agent for Disease Accompanied by Intestinal Tract Dysfunction
#676METHOD FOR EXTRACTING QUANTITATIVE INFORMATION RELATING TO AN INFLUENCE ON A CELLULAR RESPONSE
#677Methods for immortalizing cells
#678Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#679Receptor Tyrosine Kinase Signaling Pathway Analysis For Diagnosis And Therapy
#680METHODS AND COMPOSITIONS FOR AFFECTING CYCLOPHILIN A REGULATION OF KINASES IN MODULATING CELLULAR ACTIVITIES
#681QUANTITATIVE DETERMINATION OF BCL10
#682Diagnosis and Treatment of Diseases Arising from Defects in the Tuberous Sclerosis Pathway
#683MELKS as modifiers of the Rac pathway and methods of use
#684TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA
#685Modulators Of NOD2 Signalling
#686Method
#687METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#688Therameutin modulators
#689T1R HETERO-OLIGOMERIC TASTE RECEPTORS AND CELL LINES THAT EXPRESS SAID RECEPTORS AND USE THEREOF FOR IDENTIFICATION OF TASTE COMPOUNDS
#690METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#691Novel bone mineralization protein expression systems, and methods of studying their intracellular signaling pathways
#692Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
#693Increasing life span by modulation of Smek
#694T1R HETERO-OLIGOMERIC TASTE RECEPTORS AND CELL LINES THAT EXPRESS SAID RECEPTORS AND USE THEREOF FOR IDENTIFICATION OF TASTE COMPOUNDS
#695T1R HETERO-OLIGOMERIC TASTE RECEPTORS AND CELL LINES THAT EXPRESS SAID RECEPTORS AND USE THEREOF FOR IDENTIFICATION OF TASTE COMPOUNDS
#696Method for Using Division Arrested Cells in Screening Assays
#697IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
#698T1R HETERO-OLIGOMERIC TASTE RECEPTORS AND CELL LINES THAT EXPRESS SAID RECEPTORS AND USE THEREOF FOR IDENTIFICATION OF TASTE COMPOUNDS
#699Isolated cold-and-menthol-sensitive receptor (CMR1)
#700Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)
#701SPHKS as modifiers of the p53 pathway and methods of use
#702Methods of treating neurological conditions with hematopoeitic growth factors
#703RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth
#704Methods for treatment with bucindolol based on genetic targeting
#705Modulation of Wrn-Mediated Telomere-Initiated Cell Signaling
#706T1R2 binding assays
#707Human T1R2 taste receptor polypeptides
#708Agent for treating allergic or hypersensitivity condition
#709Modulation of T cell signaling threshold and T cell sensitivity to antigens
#710Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin
#711EEF2K as modifiers of the PTEN/AKT pathway and methods of use
#712Treatment for spinal muscular atrophy
#713Screening Method With The Use Of TBK1 Knockout Mouse
#714Identification of an evolutionarily conserved pathway mediating transrepression of inflammatory response genes by nuclear receptors
#715Methods and compositions for risk stratification
#716METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#717Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain
#718Methods of treating neurological conditions with hematopoeitic growth factors
#719The Redox/Fyn/c-Cbl Pathway
#720Screening assays for hedgehog agonists and antagonists
#721METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#722Methods and Compounds for Treating Inflammation
#723EPITOPES FORMED BY NON-COVALENT ASSOCIATION OF CONJUGATES
#724Methods of suppressing microglial activation
#725Method for identifying a ligand capable of selectively modulating a functional cascade involving a target, and uses thereof for high-throughput screening of molecules of interest
#726Compositions and methods for modulation of KSR1 and KSR2 interactions
#727Modulators of odorant receptors
#728Modulation of Pericyte Proliferation
#729HEDGEHOG INHIBITOR ASSAY
#730NOVEL GERMINAL KINASE PROTEINS, COMPOSITIONS AND METHODS OF USE
#731Methods of screening modulators of T2R taste receptors
#732Methods for treatment with bucindolol based on genetic targeting
#733Composition for Treating Virus Infection Disease Comprising Jab1
#734Polypeptide fragment of constitutive coactivator of PPARgamma
#735Bone mineralization protein expression systems, and methods of studying intracellular signaling pathways induced thereby
#736Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
#737METHOD FOR USING DIVISION ARRESTED CELLS IN SCREENING ASSAYS
#738FUNCTION HOMOLOGY SCREENING
#739Product and method for treatment of conditions associated with receptor-desensitization
#740FUNCTION HOMOLOGY SCREENING
#741BIOMAP ANALYSIS
#742Monitoring gene silencing and annotating gene function in living cells
#743DOMINANT NEGATIVE LIGAND DRUG DISCOVERY SYSTEM
#744Compositions and methods relating to polycystic kidney disease
#745Recombinant methods for expressing a functional umami (T1R1/T1R3) taste receptor
#746Reagents for the detection of protein phosphorylation in c-Src signaling pathways
#747Withanolide compounds as inhibitors of fibrosis and identification of molecular targets for anti-fibrotic drug development
#748DEP-1 receptor protein tyrosine phosphatase interacting proteins and related methods
#749Model Taste Cells and Methods of Use for Identifying Modulators of Taste Sensation
#750Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
#751Biological dataset profiling of asthma and atopy
#752T1R taste receptors and genes encoding same
#753Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis
#754Method for testing a compound for a therapeutic effect and a diagnostic method
#755Low-density lipoprotein receptor 6 (LRP6) as a mammary stem cell marker and related methods
#756Mammary stem cell marker
#757Mptens as Modifiers of the Pten/Igf Pathway and Methods of Use
#758Ranbp2 as Modifiers of the Pten/Igf Pathway and Methods of Use
#759Nadks as Modifiers of Branching Morphogenesis and Methods of Use
#760Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1
#761Methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3
#762Compositions and methods for altering RNAi
#763NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY NKG2D-POSITIVE CD4+ CELLS
#764Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt
#765Compositions and methods for treatment of immune-related disease
#766Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
#767Methods for Modifying Cell Motility Using Factor VIIa Antagonist
#768Efficient drug screening for protein targets
#769Pain signaling molecules
#770Methods and compositions for detecting receptor-ligand interactions in single cells
#771Methods and compositions for detecting receptor-ligand interactions in single cells
#772Methods and compositions for detecting receptor-ligand interactions in single cells
#773Reducing polyglutamine-based aggregation
#774Methods of identifying adipocyte specific genes, the genes identified, and their uses
#775Methods of preventing or treating brain ischemia or brain injury
#776HPRP4s modifiers of the p53 pathway and methods of use
#777Methods for Identifying Target Genes, Gene Expression Profiles, and Biochemical/Signal Transduction Pathways Associated with Specific Patterns of Hemodynamic Shear Stress and Atherogenesis and Uses Thereof
#778Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets
#779Biological agent that causes IL-6 receptor release
#780CELLS HAVING A SPECTRAL SIGNATURE AND METHODS OF PREPARATIONS AND USE THEREOF
#781Loc169505 as modifiers of the apc and axin pathways and methods of use
#782Flj10607 as modifier of the axin pathway and methods of use
#783Method for determining the presence of one or more ligands in a sample
#784Methods for analysis of biological dataset profiles
#785Protein tyrosine kinase substrate lat and its use in the identification of (ANT)agonists of the kinase
#786Ttbks as modifiers of the beta catenin pathway and methods of use
#787Methods for identifying compounds interacting with small membrane-bound gtp-ases
#788(+)-TRANS-4-(1-AMINOETHYL)-1-(4-PYRIDYCARBAMOYL)-CYCLOHEXANE AND METHOD FOR PROMOTING NEURAL GROWTH IN THE CENTRAL NERVOUS SYSTEM AND IN A PATIENT AT A SITE OF NEURONAL LESION
#789Reagents and method for modulating Dkk-mediated interactions
#790Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
#791Control of TGFβ signaling by km23 superfamily members
#792Genetic and pharmacological regulation of antidepressant-sensitive biogenic amine transporters through PKG/p38 map kinase
#793Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C regulation
#794Recombined cell system for deorphanizing g protein-coupled receptors
#795T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#796Methods and means for the treatment of disorders associated with cellular senescence
#797Method for identifying compounds for treatment of pain
#798Methods for characterizing signaling pathways and compounds that interact therewith
#799Cell-based assays for determining drug action
#800Compositions for the reversible thioesterification of signaling proteins and methods of using same
#801Mammalian sour/acid taste and CSF receptor genes, polypeptides and assays
#802Treatment of Alzheimer's Disease
#803Assays for sensory modulators using a sensory cell specific G-protein beta subunit
#804Neuregulin protein regulation of synaptic proteins
#805Mptens as modifers of the pten/igf pathway and methods of use
#806Computer systems and methods for inferring casuality from cellular constituent abundance data
#807Functional coupling of T1Rs and T2Rs by Gi proteins, and cell-based assays for the identification of T1R and T2R modulators
#808Ndr kinase modulators
#809POP2: NKκB-inhibiting polypeptides, nucleic acids and methods of use
#810Diaryl ureas with kinase inhibiting activity
#811Tkts as mondifiers of the beta-catenin pathway and methods of use
#812123 human secreted proteins
#813Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions
#8142-O sulfatase compositions and methods of hydrolyzing therewith
#815Inhibition of the β3 subunit of L-type Cachannels
#816Mechanism for identifying drugs for the treatment of type II diabetes
#8172-O sulfatase compositions and methods of degradation therewith
#8182-O sulfatase compositions and methods of analyzing therewith
#8192-O sulfatase nucleic acid compositions
#820Targeted fusion proteins and methods for the characterization of cellular membrane domains
#821DNA encoding mammalian phosphodiesterases
#822Methods for identifying cell surface receptor protein modulators
#823Methods of screening cyclic peptides and identifying targets therefor
#824Screening method with the use of TBK1 knockout mouse
#825Method of identifying compounds that modulate interaction of androgen receptor with beta-catenin
#826Methods to increase the capacity of high content cell-based screening assays
#827Method for sensitive measure of low level apoptosis in cells
#828Protein subcellular localization assays using split fluorescent proteins
#829Cell-based assay for the quantitative high throughput screening of gamma-aminobutyric acid-induced halide transport
#830Method for identifying a substance which mediates interaction between interleukin 22 and an interleukin 22 receptor
#831Sphks as modifiers of the p53 pathway and methods of use
#832Method for screening molecules that restore NOD1 activity in cells containing an NOD2 mutation that reduces or eliminates NOD1 activity
#833Use of active ingredients for the prophylaxis and/or therapy of viral diseases
#834Neuroprotective effects of atf6
#835CD39L3 and its role in diabetes
#836Computer systems and methods for inferring causality from cellullar constituent abundance data
#837Regulation of human p2y15 g protein-coupled receptor
#838Methods of screening and compositions for life span modulators
#839Protein fragment complementation assays for high-throughput and high-content screening
#840Novel splice variants of human epithelial sodium channel genes expressed in human taste tissue and uses thereof
#841System and method for performing G protein coupled receptor (GPCR) cell assays using waveguide-grating sensors
#842Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
#843Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#844Compositions for the treatment of tumor pathologies, comprising internalin B (ln1B) of Listeria monocytogene protein or a fragment thereof
#845Diagnostics and therapeutics for glaucoma
#846Novel screening method
#847Protein which binds to Akt2
#848Prevention and treatment of amyloid-associated disorders
#849Antagonizing nk-1 receptors inhibits consumption of substances of abuse
#850Parallel inducible cell-based kinase screen
#851Methods and agents for regulating angiotensin activity
#852Detection of activation of endothelial cells as surrogate marker for angiogenesis
#853Methods for treatment with bucindolol based on genetic targeting
#854Functional assays for identifying compounds that modulate T1R1/T1R3 (umami) taste
#855Cell microarray for profiling of cellular phenotypes and gene function
#856Glucose-transport related genes, polypeptides, and methods of use thereof
#857Modulators of Nod2 signaling
#858Harnessing network biology to improve drug discovery
#859Method for using division arrested cells in screening assays
#860Methods for regulation of stem cells
#861Cell-based kinase assay
#862Compositions, kits and assays containing reagents directed to cortactin and an ARG/ABL protein kinase
#863Cellular signaling pathway based assays, reagents and kits
#864MyD88 as a therapeutic target for cancer
#865Isolated (T1R2/T1R3) sweet taste receptors that respond to sweet taste stimuli
#866Toll-like receptor 9 modulators
#867Notch signaling in long-term memory formation
#868Gpcs as modifiers of the irrtk p21 pathways and methods of use
#869Assay methods for identifying modulators of OPSDL3 and transgenic knockouts
#870RICK3 nucleic acids and proteins
#871Modulation of deubiquitinase family members
#872Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
#873Toll-like receptor assays
#874Signals and molecular species involved in senescence
#875Predictive markers in cancer therapy
#876Methods for identifying new drug leads and new therapeutic uses for known drugs
#877Matrix analysis of gene expression in cells (magec)
#878Minrs as modifiers of insulin receptor signaling and methods of use
#879Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI)
#880Elastin prevents occlusion of body vessels by vascular smooth muscle cells
#881Natural ligand for orphan G protein coupled receptor GPR86 and methods of use
#882Protein tyrosine kinase substrate LAT and its use in the identification of (ANT) agonists of the kinase
#883Apparatus and methods for using biological material to discriminate an agent
#884Methods and compositions for detecting the activation state of multiple proteins in single cells
#885Screening methods for cognitive enhancers
#886Methods and systems for monitoring intracellular binding reactions
#887Modulators that promote cell surface expression of odorant receptors
#888Methods to prevent tumor recurrence by blockade of tgf-beta
#889Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
#890Pharmacological profiling of drugs with cell-based assays
#891Epitope testing using soluble HLA
#892Methods and compositions for treating Alzheimer's disease
#893Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
#894Method for evaluating a substance capable of effecting on endoplasmic reticulum stress-and/or amyloid beta-induced apoptosis
#895Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
#896Increasing life span by modulation of Smek
#897Functional assays for identifying compounds that modulate T1R2/T1R3 (sweet) taste
#898Promiscuous G-protein compositions and their use
#899Methods and systems for predicting protein-ligand coupling specificities
#900Methods of suppressing microglial activation